Back to catalogue
UPR
Uniphar PLC
340/1000 Overall fit
AI beneficiary 35% 20
Operating leverage 25% 42
Valuation 25% 30
Downside protection 15% 58
First-pass take
Healthcare distribution/services company with zero AI exposure or strategy. Serves 200+ pharma/medtech manufacturers with defensive, essential services. EBITDA margin compressed (4.09% to 3.87%) despite 8.6% revenue growth, showing limited near-term operating leverage. Moderate leverage at 1.90x; not aligned with AI spending strategy.
Flags
no-valuation-datadefensiveno-ai-exposuremargin-compressionrising-leverage